Results 181 to 190 of about 1,462,493 (311)
The solution bounds and fixed point iterative algorithm for the discrete coupled algebraic Riccati equation applied to automatic control [PDF]
Jianzhou Liu, Li Wang, Juan Zhang
openalex +1 more source
Coupled Fixed Point Theorems Employing CLR-Property on V -Fuzzy Metric Spaces [PDF]
Vishal Gupta+2 more
openalex +1 more source
Trastuzumab‐deruxtecan, a HER2‐targeting antibody‐drug conjugate, shows promising antitumor activity in head and neck squamous cell carcinoma with low HER2 expression. In vitro and in vivo studies demonstrated dose‐dependent cell death and tumor growth reduction in low HER2‐expressing cell lines, which correlated with drug accumulation measured using a
Abdullah Bin Naveed+8 more
wiley +1 more source
Common coupled fixed point theorems for contractive mappings in fuzzy metric spaces
Dorel Miheţ
openalex +2 more sources
Loss of primary cilia in endothelial cells promotes EndMT and vascular abnormalities in the ovarian tumor microenvironment through EphA2 activation. Using human samples, in vitro models, and endothelial‐specific Kif3a‐knockout mice, we show that primary cilia loss drives the acquisition of cancer‐associated fibroblast‐like phenotypes, thereby ...
Jin Gu Cho+11 more
wiley +1 more source
Determination of the Some Results for Coupled Fixed Point Theory in C*-Algebra Valued Metric Spaces [PDF]
Saleh Omran, Özen Özer
openalex +1 more source
This study identifies nuclear YB‐1 S102 phosphorylation as a marker associated with KRAS and FBXW7 mutations in colorectal cancer. Mutated KRAS correlates specifically with nuclear, not cytoplasmic, S102 YB‐1. These findings provide the first ex vivo evidence of this link in CRC and suggest future studies should assess the prognostic and therapeutic ...
Konstanze Lettau+9 more
wiley +1 more source
Common coupled fixed point results for operators without mixed monotone type properties and application to nonlinear integral equations [PDF]
Nabil Machrafi
openalex +1 more source
A nucleotide‐independent, pan‐RAS‐targeted DARPin elicits anti‐tumor activity in a multimodal manner
We report a Designed Ankyrin Repeat Protein that binds and inhibits RAS proteins, which serve as central cell signaling hubs and are essential for the progression of many cancers. Its unique feature is that it does not discriminate between different RAS isoforms or mutations and is capable of binding to RAS in both its active (GTP‐bound) and inactive ...
Jonas N. Kapp+13 more
wiley +1 more source